Toruner M - Search Results

1

Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study.

Yamamoto-Furusho JK, Al Harbi O, Armuzzi A, Chan W, Ponce de Leon E, Qian J, Shapina M, Toruner M, Tu CH, Ye BD, Guennec M, Sison C, Demuth D, Fadeeva O, Khan QMR. Yamamoto-Furusho JK, et al. Among authors: toruner m. Dig Liver Dis. 2020 Aug;52(8):869-877. doi: 10.1016/j.dld.2020.05.031. Epub 2020 Jun 17. Dig Liver Dis. 2020. PMID: 32563721 Free article.

2

Factor V Leiden, prothrombin G20210A and MTHFR gene mutations in inflammatory bowel disease.

Törüner M, Erkan O, Soykan I, Bozdayi M, Cetinkaya H, Yurdaydin C, Uzunalimoğlu O, Ozden A. Törüner M, et al. Turk J Gastroenterol. 2004 Dec;15(4):250-2. Turk J Gastroenterol. 2004. PMID: 16249980 Free article.

3

Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease.

Celik Y, Dagli U, Kiliç MY, Törüner M, Ozen SC, Ozkan M, Soykan I, Cetinkaya H, Ulker A, Ozden A, Bozdayi AM. Celik Y, et al. Among authors: toruner m. Scand J Gastroenterol. 2006 May;41(5):559-65. doi: 10.1080/00365520500349523. Scand J Gastroenterol. 2006. PMID: 16638698

4

NOD2/CARD15, NOD1/CARD4, and ICAM-1 gene polymorphisms in Turkish patients with inflammatory bowel disease.

Ozen SC, Dagli U, Kiliç MY, Törüner M, Celik Y, Ozkan M, Soykan I, Cetinkaya H, Ulker A, Ozden A, Bozdayi AM. Ozen SC, et al. Among authors: toruner m. J Gastroenterol. 2006 Apr;41(4):304-10. doi: 10.1007/s00535-005-1780-z. J Gastroenterol. 2006. PMID: 16741608

5

Risk factors for opportunistic infections in patients with inflammatory bowel disease.

Toruner M, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Orenstein R, Sandborn WJ, Colombel JF, Egan LJ. Toruner M, et al. Gastroenterology. 2008 Apr;134(4):929-36. doi: 10.1053/j.gastro.2008.01.012. Epub 2008 Jan 11. Gastroenterology. 2008. PMID: 18294633

6

Effects of polymorphism in G2677T/A triallelic region of MDR1 gene in Turkish patients with inflammatory bowel disease.

Sapmaz A, Ozen Karatayli SC, Dağli U, Kiliç ZM, Törüner M, Celik Y, Ozkan M, Soykan I, Cetinkaya H, Ulker A, Ozden A, Bozdayi AM. Sapmaz A, et al. Among authors: toruner m. Turk J Gastroenterol. 2008 Sep;19(3):168-73. Turk J Gastroenterol. 2008. PMID: 19115152 Free article.

7

What is the importance of anti-TNF agents in the treatment of luminal (inflammatory type) Crohn's disease?

Kabaçam G, Törüner M. Kabaçam G, et al. Among authors: toruner m. Turk J Gastroenterol. 2010 Mar;21(1):107-12. doi: 10.4318/tjg.2010.0066. Turk J Gastroenterol. 2010. PMID: 20552736 Free article. Review. No abstract available.

8

Turkish IBD Organization's Position Statement on Inflammatory Bowel Disease Management Recommendations During COVID-19 Pandemic.

Törüner M, Kalkan İH, Akyüz F, Tezel A, Çelik AF. Törüner M, et al. Turk J Gastroenterol. 2021 Jun;32(6):488-492. doi: 10.5152/tjg.2021.280721. Turk J Gastroenterol. 2021. PMID: 34405814 Free PMC article.

9

Improvement of Work Productivity and Quality of Life with Anti-Tumor Necrosis Factor Treatment Used in Crohn's Disease in Routine Clinical Practice in Turkey.

Toruner M, Basaranoglu M, Atug O, Senturk O, Akyuz F, Cekic C, Over Hamzaoglu H, Tekin F, Sezgin O, Akpinar H, Celik AF, Tezel A, Gokturk HS, Kav T. Toruner M, et al. Turk J Gastroenterol. 2022 May;33(5):406-413. doi: 10.5152/tjg.2022.21868. Turk J Gastroenterol. 2022. PMID: 35678798 Free PMC article.

10

Epigenetics of Inflammatory Bowel Diseases.

Törüner M, Ünal NG. Törüner M, et al. Turk J Gastroenterol. 2023 May;34(5):437-448. doi: 10.5152/tjg.2023.22515. Turk J Gastroenterol. 2023. PMID: 37158530 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters